SCHEMBL10396256

SCHEMBL10396256

NCCCC[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ DPP4 P27487 2/20 0.47
▸ DPP8 Q6V1X1 2/20 0.47
▸ DPP9 Q86TI2 2/20 0.47
▸ DPP7 Q9UHL4 2/20 0.47
▸ FAP Q12884 1/20 0.47
▸ ACE P12821 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30558183 0.88 MEN1 (0.44) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL29409428 0.87 OPRK1 (0.49) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL30490560 0.87 CALCRL (0.43) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL29589425 0.86 ACE (0.43) DPP4FAPACE
SCHEMBL30558185 0.86 MEN1 (0.44) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL30558196 0.86 MEN1 (0.44) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL11368293 0.85 ACE (0.43) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL11368299 0.85 ACE (0.43) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL29689560 0.84 ACE (0.47) MAPTDPP4DPP8DPP9DPP7
SCHEMBL29727257 0.84 ACE (0.41) DPP4FAPACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4921941-A TRIPEPTIDE ESTERS SCHERING CORPORATION (US) 1990-05-01 — — US claimed
WO-1989000165-A1 ORALLY ACTIVE ANTIANDROGENS SCHERING CORPORATION (US) 1989-01-12 — — WO claimed
US-4921941-A TRIPEPTIDE ESTERS SCHERING CORPORATION (US) 1990-05-01 — — US disclosed
WO-1989000165-A1 ORALLY ACTIVE ANTIANDROGENS SCHERING CORPORATION (US) 1989-01-12 — — WO disclosed
Send feedback